Does Radiation Have a Role in Advanced Stage Hodgkin’s or Non-Hodgkin Lymphoma?-Reference-Cited by-同舟云学术

Does Radiation Have a Role in Advanced Stage Hodgkin’s or Non-Hodgkin Lymphoma?

Published:2016-01 Issue:1 Volume:17 Page:
ISSN:1527-2729
Container-title:Current Treatment Options in Oncology
language:en
Short-container-title:Curr. Treat. Options in Oncol.

Author:

Specht Lena

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11864-015-0377-x.pdf

Reference84 articles.

1. Hoppe RT, Horning SJ, Rosenberg SA. The concept, evolution and preliminary results of the current Stanford clinical trials for Hodgkin’s disease. Cancer Surv. 1985;4:459–75.

2. Specht L, Gray RG, Clarke MJ, Peto R. Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin’s disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin’s Disease Collaborative Group. J Clin Oncol. 1998;16:830–43.

3. Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer. 1993;71:2342–50.

4. Aleman BM, van den Belt-Dusebout AW, de Bruin ML, van’t Veer MB, Baaijens MH, de Boer JP, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109:1878–86.

5. Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD, et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. 2015;107, djv008.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients;Clinical and Translational Radiation Oncology;2024-05

2. Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study;Journal of Cancer Research and Clinical Oncology;2023-06-08

3. Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience;La radiologia medica;2023-03-15

4. Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy;Drugs of the Future;2022

5. Outcome-based multiobjective optimization of lymphoma radiation therapy plans;The British Journal of Radiology;2021-11-01